EGFR and endometrial cancer: High risk was correlated to some pathways like cell cycle, DNA replication, ECM receptor interaction, endometrial cancer, ERBB signaling pathway, MAPK signaling pathway, mismatch repair, oocyte meiosis, purine metabolism, TGF-beta signaling pathway, and WNT signaling pathway (Figures 7(a)–7(k)).